PTC Therapeutics, Inc.
PTCT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001070081
In the last 90 days, PTC Therapeutics, Inc. insiders filed 0 open-market purchases and 11 sales; 382 institutions reported holding it in 13F filings for Q2 2026, worth $8.20B in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in PTC Therapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 284
- +25 vs. Q1 2025
- Shares held
- 79.9M
- +1.15M (+1.5%) vs. Q1 2025
- Total value
- $3.90B
- −$120.9M (−3.0%) vs. Q1 2025
- New holders
- 60
- 111 more added
- Sold out
- 35
- 80 more reduced
2 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PTCT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 382 | $8.20B |
| Q1 2026 | 352 | $6.51B |
| Q4 2025 | 353 | $7.04B |
| Q3 2025 | 294 | $5.07B |
| Q2 2025 | 284 | $3.90B |
| Q1 2025 | 261 | $4.02B |
| Q4 2024 | 240 | $3.51B |
| Q3 2024 | 203 | $2.93B |
| Q2 2024 | 199 | $2.44B |
| Q1 2024 | 184 | $2.48B |
| Q4 2023 | 174 | $2.33B |
| Q3 2023 | 181 | $1.83B |
| Q2 2023 | 206 | $3.30B |
| Q1 2023 | 203 | $3.81B |
| Q4 2022 | 203 | $2.94B |
| Q3 2022 | 213 | $3.83B |
| Q2 2022 | 182 | $2.97B |
| Q1 2022 | 184 | $2.76B |
| Q4 2021 | 179 | $3.00B |
| Q3 2021 | 184 | $2.77B |
| Q2 2021 | 183 | $3.13B |
| Q1 2021 | 208 | $3.52B |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding PTC Therapeutics, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Harvest Investment Services, LLC | 0 | $0 | 0.00% | −7,037−100.0% | Sold out |
| Mach-1 Financial Group, Inc. | 0 | $0 | 0.00% | −6,893−100.0% | Sold out |
| Bridgefront Capital, LLC | 0 | $0 | 0.00% | −6,247−100.0% | Sold out |
| Catalytic Wealth RIA, LLC | 0 | $0 | 0.00% | −6,196−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −5,721−100.0% | Sold out |
| Westfield Capital Management Co LP | 0 | $0 | 0.00% | −5,076−100.0% | Sold out |
| SIH Partners, LLLP | 0 | $0 | 0.00% | −4,962−100.0% | Sold out |
| Merit Financial Group, LLC | 0 | $0 | 0.00% | −4,028−100.0% | Sold out |
| Syon Capital LLC | 0 | $0 | 0.00% | −4,020−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −2,422−100.0% | Sold out |
| Ci Investments Inc. | 0 | $0 | 0.00% | −1,385−100.0% | Sold out |
| Hexagon Capital Partners LLC | 0 | $0 | 0.00% | −956−100.0% | Sold out |
| Coldstream Capital Management Inc | 0 | $0 | 0.00% | −707−100.0% | Sold out |
| West Paces Advisors Inc. | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −199−100.0% | Sold out |
| Boston Private Wealth LLC | 0 | $0 | 0.00% | −130−100.0% | Sold out |
| Massmutual Trust Co FSB | 0 | $0 | 0.00% | −106−100.0% | Sold out |
| Stephens Consulting, LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Global Financial Private Client, LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Lindbrook Capital, LLC | – | – | – | – | Not filed |
| Sandy Spring Bank | – | – | – | – | Not filed |